DE CESARIS, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.961
EU - Europa 1.902
AS - Asia 1.450
SA - Sud America 172
Continente sconosciuto - Info sul continente non disponibili 63
AF - Africa 37
OC - Oceania 15
Totale 6.600
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.901
RU - Federazione Russa 613
IT - Italia 536
CN - Cina 405
SG - Singapore 359
PL - Polonia 267
HK - Hong Kong 217
BR - Brasile 138
VN - Vietnam 136
IE - Irlanda 124
SE - Svezia 100
KR - Corea 97
BD - Bangladesh 85
FR - Francia 59
DE - Germania 49
CH - Svizzera 46
GB - Regno Unito 44
CA - Canada 35
IN - India 29
JO - Giordania 26
FI - Finlandia 23
ID - Indonesia 22
JP - Giappone 20
NL - Olanda 17
AU - Australia 15
AR - Argentina 13
IQ - Iraq 12
CI - Costa d'Avorio 9
MX - Messico 9
ZA - Sudafrica 9
CO - Colombia 7
TR - Turchia 7
CL - Cile 5
NG - Nigeria 5
PH - Filippine 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
PK - Pakistan 4
BJ - Benin 3
ES - Italia 3
GT - Guatemala 3
IL - Israele 3
JM - Giamaica 3
KG - Kirghizistan 3
MA - Marocco 3
MY - Malesia 3
PR - Porto Rico 3
TH - Thailandia 3
UZ - Uzbekistan 3
AT - Austria 2
CR - Costa Rica 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
HU - Ungheria 2
MT - Malta 2
NP - Nepal 2
PE - Perù 2
TN - Tunisia 2
UY - Uruguay 2
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 6.537
Salva come PNG Salva come JPEG
Città #
Santa Clara 671
Ashburn 358
Warsaw 266
Singapore 254
Hong Kong 188
Fairfield 142
San Jose 137
Dublin 115
Seoul 97
Beijing 88
Council Bluffs 80
Hefei 78
Woodbridge 73
Chandler 69
Florence 64
Milan 62
Cambridge 60
Seattle 57
Los Angeles 52
Dearborn 50
Houston 50
Ho Chi Minh City 49
Altamura 48
Buffalo 48
Lawrence 47
Bern 45
Wilmington 45
Chicago 42
New York 42
Moscow 35
Rome 35
Lauterbourg 32
Princeton 26
Hanoi 25
Munich 24
Shanghai 21
Boston 20
The Dalles 20
Kent 18
Tokyo 18
Medford 17
Bologna 15
Naples 15
Ann Arbor 14
Jakarta 14
Melbourne 13
Dallas 12
Figino 12
Paris 12
San Diego 12
Boardman 11
Phoenix 11
Salt Lake City 11
Turin 11
Mumbai 10
Orem 10
San Mateo 10
São Paulo 10
Abidjan 9
London 9
Toronto 9
Dong Ket 8
Johannesburg 8
Miano 8
Clifton 7
Denver 7
Guangzhou 7
Haiphong 7
Helsinki 7
Lappeenranta 7
Palermo 7
Atlanta 6
Chennai 6
Fontebuona 6
Prato 6
San Francisco 6
Shenzhen 6
Venice 6
Abuja 5
Baghdad 5
Bengaluru 5
Da Nang 5
Jacksonville 5
Malton 5
Montreal 5
Nanjing 5
Padua 5
Ravenna 5
Thiene 5
Turku 5
Andover 4
Ardea 4
Elk Grove Village 4
Frankfurt am Main 4
Hangzhou 4
Manchester 4
Medellín 4
Memphis 4
Newark 4
Ninh Bình 4
Totale 4.113
Salva come PNG Salva come JPEG
Nome #
Migraine-provoking substances evoke periorbital allodynia in mice 297
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score 272
Transient receptor potential channels as novel drug targets in respiratory diseases. 271
Protocol and methods for testing the efficacy of well-being therapy in chronic migraine patients: a randomized controlled trial 254
Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series 250
Mental Pain Questionnaire: An item response theory analysis 237
Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study 231
TRPA1 and other TRP channels in migraine 224
Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura 209
Chronic headaches and medication overuse 208
Mental Pain Questionnaire: Clinimetric Properties of a Potential Global Person‐Centred Outcome Measure 199
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: A post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 194
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study 189
Post onset, oral rapamycin treatment delays development of mitochondrial encephalopathy only at supramaximal doses 182
Acute and chronic triptan exposure neither alters rodent cerebral blood flow nor worsens ischemic brain injury 181
Criterion-related validity in a sample of migraine outpatients: The diagnostic criteria for psychosomatic research 179
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ) 177
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine 164
Ultra-rapid brain uptake of subcutaneous sumatriptan in the rat: Implication for cluster headache treatment 163
Predictors of sustained response and effects of the discontinuation of anti-calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraine 163
Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study 162
Migraine Models 161
Emerging Pharmacological Treatments for Migraine in the Pediatric Population 157
Epidemiology and determinants of chronic migraine: A real-world cohort study, with nested case-control analysis, in primary care in Italy 150
Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe) 149
Mental pain and pain-proneness in migraine subjects: Results from the PAINMIG cohort-study 148
Migraine during covid-19: Data from second wave pandemic in an Italian cohort 143
The role of TRP ion channels in migraine and headache 143
COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report 127
Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany 125
Mental pain as a global person-centred outcome measure 123
Multi-domain destructuring in the early phases of psychosis: a multicentric phenomenological and psychometric case-control study 120
Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort study 118
Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine 113
Placebo Effect of Verbal Instructions Coupled with Pharmacological Treatment: Results from a Randomized Controlled Trial in Migraine Patients 67
Anti-CGRP monoclonal antibodies counteract establishment of food aversive memories and chemotherapy-induced anorexia and weight loss 57
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial 52
The anti-CGRP mAb Fremanezumab reverts the anti-inflammatory effects of CGRP in vitro but does not alter disease evolution in a mouse model of progressive multiple sclerosis 40
Biodistribution of atogepant and rimegepant in mouse peripheral and central structures of relevance to migraine pathogenesis 39
Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia 39
TRPS and Migraine 37
Rimegepant as an acute treatment in a refractory migraine patient non-responder to two anti-CGRP monoclonal antibodies and triptans: Case report and pharmacological considerations 33
Migraine is a high prevalence disorder which affects a significant proportion of the general population, especially women during their central and more productive time of the life, thus causing severe disability. The genetic basis of the disease is unknown and the mechanism is poorly understood. The possibility that following a perturbation in the central nervous system, and particularly in the brainstem, trigeminal neurons become hyperexcitable and produce an uncontrolled release of sensory neuropeptides which eventually results in arterial vasodilatation and neuronal sensitization, has been gaining credit from studies in experimental animals and humans. In particular, experimental and clinical data with antagonists of the calcitonin gene-related peptide (CGRP) propose this molecule and its receptor as a major target for migraine treatment. 29
Reduction of opioid withdrawal symptoms and opioid-induced hyperalgesia by subcutaneous sumatriptan reveals central neuromodulation 24
Totale 6.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.332
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022184 0 0 7 5 7 5 4 14 15 28 38 61
2022/2023576 45 124 39 15 16 81 66 22 55 17 28 68
2023/2024275 7 28 34 25 18 24 19 57 11 14 31 7
2024/20251.957 60 174 111 255 526 261 51 124 69 152 91 83
2025/20262.376 227 260 160 165 220 73 249 158 185 206 148 325
2026/2027361 189 115 57 0 0 0 0 0 0 0 0 0
Totale 6.600